On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.81 USD | -0.39% | -5.14% | -20.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.46% | 82.73B | |
+52.93% | 803B | |
+40.97% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.37% | 244B | |
+2.17% | 226B | |
+10.42% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company